Er Richter Gedeon Vegyeszeti Gyar Nyrt utbyttet sikkert?
Richter Gedeon Vegyeszeti Gyar Nyrt har økt utbyttet i 1 år.
I løpet av de siste 10 årene har Richter Gedeon Vegyeszeti Gyar Nyrt økt denne med årlig 19,481 % økt.
På 5-års sikt økte utbyttet med 41,896 %.
Analytikerne forventer en Utdanningsvekst på 5,748% for det pågående regnskapsåret.
Richter Gedeon Vegyeszeti Gyar Nyrt Aktienanalyse
Hva gjør Richter Gedeon Vegyeszeti Gyar Nyrt?
Richter Gedeon Vegyeszeti Gyar Nyrt (Richter) is a company specialized in pharmaceutical and chemical products, with its headquarters in Budapest, Hungary. It was founded in 1901 by Gedeon Richter and has had a diverse history since then. In the 1920s, Richter began producing pharmaceuticals and became one of the leading pharmaceutical companies in Europe over the following decades. In the 1960s, the company made an important step with the introduction of the contraceptive "Anovlar," which was also a great success internationally.
Today, Richter is a globally operating company involved in various business fields. Its main divisions are pharmaceutical production, chemical manufacturing, and research and development of medications. In pharmaceutical production, Richter specializes in medicines for women's health, neurology, and pain medicine. Some of its well-known products include the painkiller "Novalgin," the hormone preparation "Divina," and the antidepressants "Cipralex" and "Lexapro." Richter also manufactures biosimilars and generics, making it an important player in the generic drug market.
Chemical manufacturing is another significant business area for Richter, producing intermediate products and fine chemicals used in various industries. This includes chemicals for the production of polymers, agrochemicals, and electronic components.
Research and development of medications are a central focus of Richter. The company operates several research facilities and maintains close relationships with academic institutions worldwide. Its goal is to discover and develop new active ingredients to treat medical conditions for which there are currently no or insufficient therapies.
Overall, Richter employs more than 12,000 people and operates in around 40 countries worldwide. It is listed on the Budapest Stock Exchange and is one of Hungary's largest publicly traded companies. In recent years, Richter has also focused on the Asian market and plans to further expand its activities in this region. In addition to the production of generics and chemicals, the company aims to distribute its own pharmaceuticals in China and other Asian countries.
In summary, Richter is a diversified company active in various fields, specializing primarily in the production of high-quality pharmaceuticals. With its long-standing experience, high quality standards, and broad product range, Richter is one of the key players in the pharmaceutical industry in Europe and worldwide. Richter Gedeon Vegyeszeti Gyar Nyrt er et av de mest populære selskapene på Eulerpool.com.Aksjespareplaner tilbyr en attraktiv mulighet for investorer å bygge opp formue over tid. En av de største fordelene er den såkalte kostnadsgjennomsnittseffekten: Ved regelmessig å investere et fast beløp i aksjer eller aksjefond, kjøper man automatisk flere andeler når prisene er lave, og færre når de er høye. Dette kan føre til en lavere gjennomsnittspris per andel over tid. I tillegg gir aksjespareplaner også småsparere tilgang til dyre aksjer, siden de kan delta med små beløp. Den regelmessige investeringen fremmer også en disiplinert investeringsstrategi og hjelper med å unngå emosjonelle beslutninger, som impulsiv kjøping eller salg. Videre drar investorer nytte av potensiell verdistigning på aksjene, samt utbytteutdelinger som kan reinvesteres, noe som forsterker rentes renteeffekten og dermed veksten av det investerte kapitalet.